|
Stock-based compensation - Stock-Based Compensation - Narrative (Details) (USD $)
|
9 Months Ended | 12 Months Ended | 0 Months Ended | 9 Months Ended | 12 Months Ended | 9 Months Ended | 12 Months Ended | 12 Months Ended | 9 Months Ended | 12 Months Ended | 9 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2013
|
Sep. 30, 2012
|
Dec. 31, 2011
|
Dec. 10, 2011
Tecogen
|
Sep. 30, 2013
Tecogen
|
Dec. 31, 2012
Tecogen
|
Dec. 31, 2011
Tecogen
|
Dec. 31, 2010
Tecogen
|
Dec. 31, 2011
Tecogen
Exercise price $2.60 per share
|
Dec. 31, 2010
Tecogen
Exercise price $2.60 per share
|
Dec. 31, 2011
Tecogen
Exercise price $2.80 per share
|
Dec. 31, 2012
Tecogen
Exercise price $3.20 per share
|
Dec. 31, 2012
Tecogen
Stock options
|
Dec. 31, 2011
Tecogen
Stock options
|
Dec. 31, 2010
Tecogen
Stock options
|
Sep. 30, 2013
Tecogen
Restricted stock
|
Dec. 31, 2012
Tecogen
Restricted stock
|
Dec. 31, 2011
Tecogen
Restricted stock
|
Dec. 31, 2010
Tecogen
Restricted stock
|
Dec. 31, 2009
Tecogen
Restricted stock
|
Dec. 31, 2011
Tecogen
Restricted stock
Six months after an initial public offering
|
Sep. 30, 2013
Tecogen
Amended Plan
Stock options
|
Dec. 31, 2012
Tecogen
Amended Plan
Stock options
|
Dec. 31, 2011
Tecogen
Amended Plan
Stock options
|
Dec. 31, 2010
Tecogen
Amended Plan
Stock options
|
Dec. 31, 2006
Tecogen
Amended Plan
Stock options
|
Sep. 30, 2013
Ilois
|
Dec. 31, 2012
Ilois
|
Dec. 31, 2011
Ilois
|
Dec. 31, 2010
Ilois
|
Sep. 30, 2013
Ilois
Restricted stock
|
Dec. 31, 2012
Ilois
Restricted stock
|
Dec. 31, 2011
Ilois
Restricted stock
|
Dec. 31, 2010
Ilois
Restricted stock
|
Dec. 31, 2009
Ilois
Restricted stock
|
Dec. 31, 2011
Ilois
Restricted stock
180 days after an initial public offering of Ilios
|
Dec. 31, 2011
Ilois
Restricted stock
3 years after initial public offering of Ilios
|
Sep. 30, 2013
Ilois
2009 Plan
|
Dec. 31, 2012
Ilois
2009 Plan
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||||||||||||||||||||||||||
| Shares of common stock reserved for future issuance | 1,838,750 | 1,838,750 | 1,000,000 | ||||||||||||||||||||||||||||||||||||
| Number of shares remaining available for future issuance | 97,683 | 135,183 | 161,433 | 721,683 | |||||||||||||||||||||||||||||||||||
| Maximum number of shares allowable for issuance | 97,683 | 2,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||
| Options granted | 37,500 | 17,500 | 511,500 | 25,000 | 480,250 | 25,000 | 31,250 | 17,500 | 0 | 50,000 | 225,000 | 0 | |||||||||||||||||||||||||||
| Options granted, exercise price in usd per share | $ 3.20 | $ 3.20 | $ 2.60 | $ 2.60 | $ 2.60 | $ 2.80 | $ 3.20 | $ 0 | $ 0.50 | $ 0.50 | $ 0 | ||||||||||||||||||||||||||||
| Fair value of options issued | $ 20,223 | $ 508,586 | $ 24,446 | $ 9,750 | $ 42,065 | ||||||||||||||||||||||||||||||||||
| Weighted-average grant date fair value of options granted | $ 1.00 | $ 0.96 | $ 1.12 | $ 1.16 | $ 0.20 | $ 0.19 | |||||||||||||||||||||||||||||||||
| Options repurchased from consultant | 12,500 | ||||||||||||||||||||||||||||||||||||||
| Options repurchased from consultant, exercise price in usd per share | $ 1.00 | ||||||||||||||||||||||||||||||||||||||
| Options repurchased from consultant, fair value in usd per share | $ 3.20 | ||||||||||||||||||||||||||||||||||||||
| Options repurchased from consultant, charge to Stockholders' Equity | 12,500 | 12,500 | 12,500 | ||||||||||||||||||||||||||||||||||||
| Restricted stock granted | 0 | 0 | 50,000 | 19,211 | 0 | 0 | 200,000 | 0 | |||||||||||||||||||||||||||||||
| Restricted stock granted, price in usd per share | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||||||||||||
| Award vesting percentage | 25.00% | 25.00% | |||||||||||||||||||||||||||||||||||||
| Award vesting period | 4 years | 4 years | 4 years | 6 months | 0 years | 4 years | 180 years | 3 years | |||||||||||||||||||||||||||||||
| Award expiration period | 10 years | 10 years | 10 years | 10 years | 10 years | ||||||||||||||||||||||||||||||||||
| Recognized stock-based compensation | (8,105) | 232,828 | 136,184 | 396,724 | 185,901 | 59,361 | 47,648 | 11,135 | |||||||||||||||||||||||||||||||
| Unvested restricted stock outstanding | 361,570 | 399,070 | 483,317 | 433,317 | 414,106 | 310,000 | 510,000 | 560,000 | 360,000 | 360,000 | |||||||||||||||||||||||||||||
| Compensation cost related to unvested restricted stock awards and stock option awards not yet recognized | $ 107,651 | $ 183,230 | $ 537,540 | $ 141,859 | $ 67,493 | $ 122,056 | $ 27,839 | ||||||||||||||||||||||||||||||||
| Compensation cost not yet recognized, weighted average period of recognition | 1 year 6 months 22 days | 2 years 8 months 19 days | 1 year 8 months 1 day | ||||||||||||||||||||||||||||||||||||